EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Differentiation of Human Pluripotent Cells into Pancreatic Beta Cells for Disease Modeling and Cell Replacement Therapy for Diabetes

Anna A Barinova iD, Alexandra Y Bogomolova, Alexandra N Bogomazova iD, Alyona A Borisova iD, Sergey L Kiselev, Alexandra V Panova

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178749 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anna A Barinova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, 119435 Moscow, Russia. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Cell Differentiation, Diabetes Mellitus, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) is a metabolic disease characterized by persistent hyperglycemia, resulting from defects in insulin secretion or impaired insulin action. In cases of severe pancreatic cell dysfunction and deficiency, the primary treatment remains lifelong insulin injections. A potential alternative is allogeneic pancreatic cell transplantation from a donor, which can stabilize glucose levels. However, the scarcity of donor material and the risk of immune rejection limit the widespread use of this approach. An alternative solution involves using in vitro-derived insulin-producing cells generated through the differentiation of pluripotent stem cells (PSCs), which could overcome the shortage of transplantable material. Furthermore, patient-specific cells—obtained directly from the patient via reprogramming of blood or skin cells into induced pluripotent stem cells (iPSCs)—would avoid immune rejection. Advances in this field have led to the active development and optimization of PSC differentiation into hormone-producing cells worldwide, with more than hundred patients dosed in clinical trials with ESC-derived cells and the single trial of iPSC-derived cells. This review highlights recent progress and prospects in generating insulin-producing cells from human PSCs, their applications in therapy development and disease modeling, as well as the current challenges and potential solutions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsCell DifferentiationDiabetes MellitusInduced Pluripotent Stem CellsCell- and Tissue-Based TherapyPluripotent Stem CellsHumansAnimals

Stichwörter der Autor:innen

DM Type 1diabetesiPSCinsulin

Autor:innen und Institutionen

  • Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, 119435 Moscow, Russia.
  • Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia.
  • Vavilov Institute of General Genetics, Russian Academy of Sciences, 117971 Moscow, Russia.

ORCID-Profile: Anna A Barinova, Alexandra N Bogomazova, Alyona A Borisova

Förderung

  • Russian Science Foundation

Zitieren

APA

Barinova, A. A., Bogomolova, A. Y., Bogomazova, A. N., Borisova, A. A., Kiselev, S. L., & Panova, A. V. (2025). Differentiation of Human Pluripotent Cells into Pancreatic Beta Cells for Disease Modeling and Cell Replacement Therapy for Diabetes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178749

Vancouver

Barinova AA, Bogomolova AY, Bogomazova AN, Borisova AA, Kiselev SL, Panova AV. Differentiation of Human Pluripotent Cells into Pancreatic Beta Cells for Disease Modeling and Cell Replacement Therapy for Diabetes. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178749

BibTeX
@article{Barinova2025,
  author = {Barinova, Anna A and Bogomolova, Alexandra Y and Bogomazova, Alexandra N and Borisova, Alyona A and Kiselev, Sergey L and Panova, Alexandra V},
  title = {Differentiation of Human Pluripotent Cells into Pancreatic Beta Cells for Disease Modeling and Cell Replacement Therapy for Diabetes},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178749}
}
Kostenlos starten →